Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2

N. E. Kay, M. M. Oken, J. J. Mazza, E. C. Bradley, J. H. Glick, P. Wiernik, J. M. Bennett, J. Kirkwood

Research output: Contribution to journalArticle

19 Scopus citations
Original languageEnglish (US)
Pages (from-to)475-478
Number of pages4
JournalNouvelle Revue Francaise d'Hematologie
Volume30
Issue number5-6
StatePublished - Dec 1 1988

ASJC Scopus subject areas

  • Hematology

Cite this

Kay, N. E., Oken, M. M., Mazza, J. J., Bradley, E. C., Glick, J. H., Wiernik, P., Bennett, J. M., & Kirkwood, J. (1988). Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2. Nouvelle Revue Francaise d'Hematologie, 30(5-6), 475-478.